ARCHIVES

ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Letter to the Editor: A Victory for Research, But Real Work Is Ahead

November 26, 1999

US Oncology Renegotiates Agreements To Operate Under Net Earnings Model.

March 30, 2001

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

May 14, 2010

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

February 12, 1999

NIH Panel finalizes Consensus Statement; Two Panelists Join In Minority Opinion

March 28, 1997